| [1] |
MA J, SONG X, LI M, et al. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy[J]. Microbiol Res, 2023, 266: 127249. doi: 10.1016/j.micres.2022.127249 .
doi: 10.1016/j.micres.2022.127249
|
| [2] |
CHINET 数据云. CHINET中国细菌耐药监测网 [EB/OL]. [2025-06-08]. .
|
| [3] |
YAO H, YANG Y, YAO H, et al. Development of prediction models for carbapenem-resistant Klebsiella pneumoniae acquisition and prognosis in adult patients[J]. Front Pharmacol, 2024, 15: 1439116. doi: 10.3389/fphar.2024.1439116 .
doi: 10.3389/fphar.2024.1439116
|
| [4] |
ARATO V, RASO M M, GASPERINI G, et al. Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat[J]. Int J Mol Sci, 2021, 22(8): 4042. doi: 10.3390/ijms22084042 .
doi: 10.3390/ijms22084042
|
| [5] |
SNELL K I E, LEVIS B, DAMEN J A A, et al. Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA)[J]. BMJ, 2023, 381:e073538. doi: 10.1136/bmj-2022-073538 .
doi: 10.1136/bmj-2022-073538
|
| [6] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing:M100-S34 [S/OL]. [2025-05-10]. .
|
| [7] |
LOU T, DU X, ZHANG P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case–control and cohort study[J]. J Infect, 2022, 84(5): 637-647. doi: 10.1016/j.jinf.2022.03.010 .
doi: 10.1016/j.jinf.2022.03.010
|
| [8] |
SADER H S, MENDES R E, STREIT J M, et al. Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)[J]. Diagn Microbiol Infect Dis, 2022, 102(1): 115557. doi: 10.1016/j.diagmicrobio.2021.115557 .
doi: 10.1016/j.diagmicrobio.2021.115557
|
| [9] |
王颖,邬巧玲,应娇茜.内科重症监护病房耐碳青霉烯肠杆菌定植情况及耐药性[J]. 实用医学杂志, 2022, 38(8):970-973. doi: 10.3969/j.issn.1006-5725.2022.08.011 .
doi: 10.3969/j.issn.1006-5725.2022.08.011
|
| [10] |
WANG Z, QIN R R, HUANG L, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection[J]. Chin Med J (Engl), 2018, 131(1): 56-62. doi: 10.4103/0366-6999.221267 .
doi: 10.4103/0366-6999.221267
|
| [11] |
ALEIDAN F A S, ALKHELAIFI H, ALSENAID A, et al. Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: A matched case-control study[J]. Expert Rev Anti Infect Ther, 2021, 19(3): 393-398. doi: 10.1080/14787210.2020.1822736 .
doi: 10.1080/14787210.2020.1822736
|
| [12] |
ZHU W, YUAN Z, ZHOU H. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: A systematic review and meta-analysis[J]. Antimicrob Resist Infect Control, 2020, 9(1): 23. doi: 10.1186/s13756-020-0686-0 .
doi: 10.1186/s13756-020-0686-0
|
| [13] |
CHU W, HANG X, LI X, et al. Bloodstream infections in patients with rectal colonization by carbapenem-resistant Enterobacteriaceae: A prospective cohort study[J]. Infect Drug Resist, 2022, 15: 6051-6063. doi: 10.2147/IDR.S383688 .
doi: 10.2147/IDR.S383688
|
| [14] |
COLANERI M, GIORDANI P, MILANESI S, et al. From Colonisation to Infection: Assessing the BSI Potential in Patients with KPC, NDM, VRE and CRAB Rectal Colonisation[J]. Infect Dis Ther, 2025, 14(10): 2359-2372. doi: 10.1007/s40121-025-01222-2 .
doi: 10.1007/s40121-025-01222-2
|
| [15] |
GAO S, YAN R, ZHANG S, et al. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study[J]. J Glob Antimicrob Resist, 2024, 36: 96-104. doi: 10.1016/j.jgar.2023.12.007 .
doi: 10.1016/j.jgar.2023.12.007
|
| [16] |
QIN X, WU S, HAO M, et al. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China[J]. J Infect Dis, 2020, 221(): S206-S214. doi: 10.1093/infdis/jiz622 .
doi: 10.1093/infdis/jiz622
|
| [17] |
LIU P, LI X, LUO M, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis[J]. Microb Drug Resist, 2018, 24(2): 190-198. doi: 10.1089/mdr. 2017.0061 .
doi: 10.1089/mdr. 2017.0061
|
| [18] |
LIANG X, CHEN P, DENG B, et al. Outcomes and risk factors of bloodstream infections caused by carbapenem-resistant and non-carbapenem-resistant Klebsiella pneumoniae in China[J]. Infect Drug Resist, 2022, 15: 3161-3171. doi: 10.2147/IDR.S367588 .
doi: 10.2147/IDR.S367588
|
| [19] |
XIAO T, ZHU Y, ZHANG S, et al. A retrospective analysis of risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients[J]. J Infect Dis, 2020, 221(): S174-S183. doi: 10.1093/infdis/jiz559 .
doi: 10.1093/infdis/jiz559
|
| [20] |
YUAN Y, WANG J, YAO Z, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infections and outcomes[J]. Infect Drug Resist, 2020, 13: 207-215. doi: 10.2147/IDR.S223243 .
doi: 10.2147/IDR.S223243
|
| [21] |
LOU T, DU X, ZHANG P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case–control and cohort study[J]. J Infect, 2022, 84(5): 637-647. doi: 10.1016/j.jinf. 2022. 03.010 .
doi: 10.1016/j.jinf. 2022. 03.010
|
| [22] |
程玉谦,王悦.碳青霉烯耐药高毒力肺炎克雷伯菌的研究进展[J]. 实用医学杂志, 2022, 38(22):2874-2879. doi: 10.3969/j.issn.1006-5725.2022.22.020 .
doi: 10.3969/j.issn.1006-5725.2022.22.020
|
| [23] |
LEI T, LIAO B, YANG L R, et al. Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat[J]. Microbiol Res, 2024, 288: 127839. doi: 10.1016/j.micres.2024.127839 .
doi: 10.1016/j.micres.2024.127839
|
| [24] |
WANG Q, WANG R, Wang S, et al. Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: An epidemiological, spatial, genomic analysis[J]. Drug Resist Updat, 2024, 74: 101083. doi: 10.1016/j.drup.2024.101083 .
doi: 10.1016/j.drup.2024.101083
|
| [25] |
LIU E, JIA P, LI X, et al. In vitro and in vivo effect of antimicrobial agent combinations against carbapenem-resistant Klebsiella pneumoniae with different resistance mechanisms in China[J]. Infect Drug Resist, 2021, 14: 917-928. doi: 10.2147/IDR.S292431 .
doi: 10.2147/IDR.S292431
|
| [26] |
KARAMPATAKIS T, TSERGOULI K, BEHZADI P. Carbapenem-resistant Klebsiella pneumoniae: Virulence factors, molecular epidemiology and latest updates in treatment options[J]. Antibiotics (Basel), 2023, 12(2): 234. doi: 10.3390/antibiotics12020234 .
doi: 10.3390/antibiotics12020234
|
| [27] |
PU D, ZHAO J, CHANG K, et al. “Superbugs” with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: The rise of such emerging nosocomial pathogens in China[J]. Sci Bull (Beijing), 2023, 68(21): 2658-2670. doi: 10.1016/j.scib. 2023.09.040 .
doi: 10.1016/j.scib. 2023.09.040
|
| [28] |
LIAO Q, FENG Z, LIN H, et al. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development[J]. Front Cell Infect Microbiol, 2023, 13: 1109418. doi: 10.3389/fcimb.2023.1109418 .
doi: 10.3389/fcimb.2023.1109418
|